TWEAK/Fn14 signalling in Breast Cancer (MAFG ChIP-seq)
This study explores the transcriptiomic and epigenetic roles of TWEAK/Fn14 signalling in Breast Cancer Overall design: Breast cancer cell lines were treated with TWEAK for 48h then harvested for MAFG ChIP-seq